Host

Christa Rhiner, Stem Cells and Regeneration Lab

Venue

Seminar room

The Champalimaud Foundation has always been at the intersection of cutting-edge science, and exceptional care. 

Specialising in cutting-edge cancer treatment, neuropsychiatry, and experimental clinical research, the Champalimaud Clinical Centre is committed to advancing personalised medicine through groundbreaking research, merging advanced technology with human-centred care.

Watch the video to see how the Champalimaud Foundation has been transforming healthcare and improving lives for the past 20 years—and how we’ll continue to do so in the future.

An international team of scientists, including a principal investigator in neuroscience from the Champalimaud Foundation, in Lisbon, has analysed the way expert London taxi drivers plan their route in advance every time they pick up passengers. It is the first time a study about human planning has been performed in a real-world, large-scale environment. Their results are published today (23rd of January) in the Proceedings of the National Academy of Sciences. 

Over the past decade, interest in psychedelics—including psilocybin, LSD, and MDMA—as treatments for psychiatric disorders has grown exponentially among scientists, mental health professionals, the media, and the public.

From groundbreaking scientific research to compassionate, patient-centered clinical care, the Foundation is committed to developing innovative solutions for complex challenges, all with the goal of improving lives and inspiring hope.

Founded in the beginning of the 21st century, it carries forward the visionary legacy of António Champalimaud, advancing science and healthcare for the greater good of humanity.

Join us in discovering how, together, we are shaping a brighter future.